Literature DB >> 15723354

Response of malignant B lymphocytes to ionizing radiation: gene expression and genotype.

Heidi Lyng1, Kirsti S Landsverk, Elin Kristiansen, Paula M DeAngelis, Anne H Ree, Ola Myklebost, Eivind Hovig, Trond Stokke.   

Abstract

The human malignant B-lymphocyte cell lines Reh and U698 show arrest in G2 phase after ionizing radiation (IR), but only Reh cells arrest in G1 phase and die by apoptosis. We have used cDNA microarrays to measure changes in gene expression at 2, 4 and 6 hr after irradiation of Reh and U698 cells with 0.5 and 4 Gy in order to begin exploring the molecular mechanisms underlying the phenotypic changes. We also investigated whether gene expression changes could be caused by possible aberrations of genes, as measured by comparative genomic hybridization. Reh cells showed upregulation of CDKN1A that likely mediated the G1 arrest. In contrast, U698 cells have impaired function of TP53 protein and no activation of CDKN1A, suppressing the arrest in G1. The G2 arrest in both cell lines was likely due to repression of PLK1 and/or CCNF. IR-induced apoptosis in Reh cells was probably mediated by TP53 and CDKN1A, whereas a high expression level of MCL1, caused by gene amplification, and activation of the NFKB pathway may have suppressed the apoptotic response in U698 cells. Genes suggested to be involved in apoptosis were activated long before this phenotype was detectable and showed the same temporal expression profiles as genes involved in cell cycle arrest. Our results suggest that differences in functionality and/or copy number of several genes involved in IR-regulated pathways contributed to the phenotypic differences between Reh and U698 cells after IR, and that multiple molecular factors control the radiation response of malignant B lymphocytes. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 15723354     DOI: 10.1002/ijc.20962

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

1.  Genome-wide analysis of abdominal and pleural malignant mesothelioma with DNA arrays reveals both common and distinct regions of copy number alteration.

Authors:  Alain C Borczuk; Jianming Pei; Robert N Taub; Brynn Levy; Odelia Nahum; Jinli Chen; Katherine Chen; Joseph R Testa
Journal:  Cancer Biol Ther       Date:  2016-02-06       Impact factor: 4.742

2.  Identification of key genes for carcinogenic pathways associated with colorectal adenoma-to-carcinoma progression.

Authors:  Anke H Sillars-Hardebol; Beatriz Carvalho; Meike de Wit; Cindy Postma; Pien M Delis-van Diemen; Sandra Mongera; Bauke Ylstra; Mark A van de Wiel; Gerrit A Meijer; Remond J A Fijneman
Journal:  Tumour Biol       Date:  2010-01-21

3.  Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery.

Authors:  Paula M De Angelis; Debbie H Svendsrud; Katherine L Kravik; Trond Stokke
Journal:  Mol Cancer       Date:  2006-05-18       Impact factor: 27.401

4.  Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer.

Authors:  Heidi Lyng; Runar S Brøvig; Debbie H Svendsrud; Ruth Holm; Olav Kaalhus; Kjetil Knutstad; Halldis Oksefjell; Kolbein Sundfør; Gunnar B Kristensen; Trond Stokke
Journal:  BMC Genomics       Date:  2006-10-20       Impact factor: 3.969

5.  Replication-induced DNA damage after PARP inhibition causes G2 delay, and cell line-dependent apoptosis, necrosis and multinucleation.

Authors:  Idun Dale Rein; Kirsti Solberg Landsverk; Francesca Micci; Sebastian Patzke; Trond Stokke
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 6.  A cyclin without cyclin-dependent kinases: cyclin F controls genome stability through ubiquitin-mediated proteolysis.

Authors:  Vincenzo D'Angiolella; Mine Esencay; Michele Pagano
Journal:  Trends Cell Biol       Date:  2012-11-19       Impact factor: 20.808

7.  Deregulated Levels of the NF-κB1, NF-κB2, and Rel Genes in Ukrainian Patients with Leukemia and Lymphoma in the Post-Chernobyl Period.

Authors:  Hakan Savlı; Ramis Ufuk Akkoyunlu; Naci Çine; Daniil F Gluzman; Michael P Zavelevich; Lilia M Sklyarenko; Stella V Koval; Deniz Sünnetçi
Journal:  Turk J Haematol       Date:  2015-04-27       Impact factor: 1.831

8.  Inhibition of IKK-NFκB pathway sensitizes lung cancer cell lines to radiation.

Authors:  Avgi Tsolou; Maria Liousia; Dimitra Kalamida; Stamatia Pouliliou; Alexandra Giatromanolaki; Michael Koukourakis
Journal:  Cancer Biol Med       Date:  2017-08       Impact factor: 4.248

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.